Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor
DRKS00017102Phase 4Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
Phase 4, randomised trial of andexanet alfa in intracerebral hemorrhage (ICH) (2 arms), sponsored by Alexion Pharmaceuticals. Started Aug 2019; status: completed.
02
Drugs
andexanet alfa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on DRKS00017102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017102.